https://epz-6438inhibitor.com/....prediction-of-man-fe
No cases of serious adverse events were observed. Low-certainty evidence indicated a minor difference in irritability (MD -350, 95% CI -639 to -61). The galantamine and risperidone group saw a greater decrease in irritability scores on the subscale post-intervention than the placebo group. Following the intervention, a comparison of hyperactivity levels across the groups yielded no evidence of a difference (MD -520, 95% CI -1051 to 011). Evaluation of general health an
Like
Comment
Share
